CF
Therapeutic Areas
Hsiri Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mycobacterial Diseases Program | Tuberculosis (TB) and Non-Tuberculous Mycobacterial (NTM) Infections | Pre-clinical |
| Drug-Resistant Bacterial Infections Program | Infections due to usual bacterial pathogens resistant to current treatments | Research/Pre-clinical |
| Drug-Resistant Fungal Infections Program | Infections due to drug-resistant fungal pathogens | Research/Pre-clinical |